Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection

被引:47
|
作者
Gyetko, MR
Sud, S
Chen, GH
Fuller, JA
Chensue, SW
Toews, GB
机构
[1] Ann Arbor Vet Affairs Med Ctr, Pulm & Crit Care Med Div, Dept Internal Med, Ann Arbor, MI 48105 USA
[2] Ann Arbor Vet Affairs Med Ctr, Pulm & Crit Care Med Div, Dept Pathol, Ann Arbor, MI 48105 USA
[3] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA
来源
JOURNAL OF IMMUNOLOGY | 2002年 / 168卷 / 02期
关键词
D O I
10.4049/jimmunol.168.2.801
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Urokinase-type plasminogen activator (uPA)(-/-) mice cannot mount protective host defenses during infection with the opportunistic yeast Cryptococcus neoformaus (52D). Because effective host defense against C. neoformans requires specific immune responses and the generation of type 1 (T1) cytokines, we determined how the absence of uPA impacts these processes. Wild-type (WT) and uPA(-/-) mice were inoculated with C. neoformans. Macrophage antifungal activity was assessed histologically, T lymphocyte responses in vivo and proliferation in vitro were quantified, and cytokine concentrations were determined by ELISA. uPA(-/-) macrophages have impaired antimicrobial activity. Regional lymph nodes of infected uPA(-/-) mice contained fewer cells than WT, suggesting impaired T cell proliferation in response to the pathogen in vivo. In vitro, uPA(-/-) T lymphocytes had impaired proliferative responses to C. neoformans rechallenge compared with WT. Infected WT mice generated T1 cytokines in the lung, characterized by high levels of IFN-gamma and IL-12. uPA(-/-) mice had decreased levels of IFN-gamma and IL-12, and increased IL-5, a type 2 cytokine. In the absence of uPA, the cytokine profile of regional lymph nodes shifted from a T1 pattern characterized by IFN-gamma and IL-2 to a weak, nonpolarized response. We conclude that in the absence of uPA, lymphocyte proliferative responses are diminished, and mice fail to generate protective T1 cytokines, resulting in impaired antimicrobial activity. This study provides novel evidence that uPA is a critical modulator of immune responses and of immune cell effector functions in vivo.
引用
收藏
页码:801 / 809
页数:9
相关论文
共 50 条
  • [1] Urokinase-type plasminogen activator
    Crippa, Massimo P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (04): : 690 - 694
  • [2] The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
    Carriero, Maria Vincenza
    Stoppelli, Maria Patrizia
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (19) : 1944 - 1961
  • [3] MEKK1 is required for inducible urokinase-type plasminogen activator expression
    Witowsky, J
    Abell, A
    Johnson, NL
    Johnson, GL
    Cuevas, BD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 5941 - 5946
  • [4] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [5] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [6] A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages
    Handley, MA
    Steigbigel, RT
    Morrison, SA
    JOURNAL OF VIROLOGY, 1996, 70 (07) : 4451 - 4456
  • [7] Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
    Akinci, Bans
    Terzi, Cem
    Sevindik, Gokmen
    Yuksel, Faize
    Tunc, Ulku Aybuke
    Tunali, Sunay
    Yesil, Sena
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 844 - 849
  • [8] Nuclear translocation of urokinase-type plasminogen activator
    Stepanova, V.
    Kuo, A.
    Higazi, A.
    Yarovoi, S.
    Bdeir, K.
    Cines, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 228 - 228
  • [9] Plasma clearance of urokinase-type plasminogen activator
    van der Kaaden, ME
    Rijken, DC
    van Berkel, TJC
    Kuiper, J
    FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 (04): : 251 - 258
  • [10] Urokinase-type plasminogen activator, an endogenous antibiotic
    Jin, T
    Bokarewa, M
    Tarkowski, A
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (03): : 429 - 437